NCT04241328 Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery
| NCT ID | NCT04241328 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medtronic Cardiac Surgery |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2020-01-09 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2020-01-09 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this observational, multi-center prospective, post-market registry is to confirm real-world device safety and performance, to ensure the continued acceptability of identified risks, and detect emerging risks.
Eligibility Criteria
Inclusion Criteria: * Subject or legally authorized representative provides written data release and/or informed consent per institution and/or geographical requirements prior to discharge from participating registry hospital. * Subject will undergo or underwent a procedure in which an eligible Medtronic CS product is/was used. Exclusion Criteria: * Currently participating in an interventional drug or device study which may induce confounding factor(s) to the results from this Registry
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04241328 clinical trial?
This trial is open to participants of all sexes, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04241328 currently recruiting?
Yes, NCT04241328 is actively recruiting participants. Contact the research team at lisa.lindelauf@medtronic.com for enrollment information.
Where is the NCT04241328 trial being conducted?
This trial is being conducted at Vienna, Austria, Genk, Belgium, Leuven, Belgium, Angers, France and 10 additional locations.
Who is sponsoring the NCT04241328 clinical trial?
NCT04241328 is sponsored by Medtronic Cardiac Surgery. The trial plans to enroll 5,000 participants.